Difference between revisions of "Team:Technion Israel"

Line 71: Line 71:
 
<div class="main2">
 
<div class="main2">
 
<a href="https://2015.igem.org/Team:Technion_Israel/Team">Team</a>
 
<a href="https://2015.igem.org/Team:Technion_Israel/Team">Team</a>
<span class="btn-bg5"></span>
+
<span class="btn-bg2"></span>
 
<div class="sub2">
 
<div class="sub2">
 
<a href="https://2015.igem.org/Team:Technion_Israel/Team/About_Us">About&nbsp;Us</a>
 
<a href="https://2015.igem.org/Team:Technion_Israel/Team/About_Us">About&nbsp;Us</a>
Line 80: Line 80:
 
<div class="main3">
 
<div class="main3">
 
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook">Lab&nbsp;Notebook</a>
 
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook">Lab&nbsp;Notebook</a>
<span class="btn-bg2"></span>
+
<span class="btn-bg3"></span>
 
<div class="sub3">
 
<div class="sub3">
 
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Overview">Overview</a>
 
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Overview">Overview</a>
Line 97: Line 97:
 
<div class="main5">
 
<div class="main5">
 
<a href="https://2015.igem.org/Team:Technion_Israel/Judging_Criteria">Judging&nbsp;Criteria</a>
 
<a href="https://2015.igem.org/Team:Technion_Israel/Judging_Criteria">Judging&nbsp;Criteria</a>
<span class="btn-bg3"></span>
+
<span class="btn-bg5"></span>
 
<div class="sub5">
 
<div class="sub5">
 
<a href="https://2015.igem.org/Team:Technion_Israel/Parts">Parts</a>
 
<a href="https://2015.igem.org/Team:Technion_Israel/Parts">Parts</a>

Revision as of 15:45, 21 August 2015

Team: Technion 2015

Hello! Welcome to our temporary wiki page!

Our team is developing a treatment for male pattern baldness.

Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3α-hydroxysteroid dehydrogenase (3-α-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.

Our project consists of 3 main parts: 3-α-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!

Contact Us